MPL mutations in MPN patients have traditionally been characterized using melting curve assays combined with Sanger sequencing [12], [13], quantitative-PCR [14], [15], or, more recently, deep sequencing [16], [17]. The gene discussed is MPL; the disease is myeloproliferative neoplasm.